Nocopi Technologies, Inc.

NNUP

CIK 0000888981 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$269K
↓-54.6% -$323Kvs FY2024 (Q4)
Operating Income
$121K
↓-55.1% -$148Kvs FY2024 (Q4)
Net Income
$115K
↓-56.3% -$148Kvs FY2024 (Q4)
Gross Profit
$171K
↓-47.3% -$153Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
33/100
  • Profitability
    0ROIC -3.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 45.02 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.11x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -54.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -37.0% · trend +169.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project NNUP's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$1.14
Total enterprise IV
$12M
Diluted shares
0.01B
Terminal PV
$9M (72% of total)
Year-5 FCF
$1M
YearProjected FCFDiscounted PV
+1$771K$701K
+2$833K$688K
+3$899K$676K
+4$971K$663K
+5$1M$651K
Terminal$14M$9M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$0
investment in PP&E
Stock-based comp (TTM)
$126K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$14M
everything owned
Total liabilities
$282K
everything owed
Stockholders' equity
$14M
shareholder claim

Recent performance · 58 quarters

Revenue↓-54.6% -$323K
$269K
Net Income↑+89.3% +$224K
$-27K
Free Cash Flow
$56K
Operating Margin↑+35.2pts
-37.0%

Drill down